Diabetes

Ranolazine added to glimepiride cuts HbA1c in T2DM

(HealthDay)—For patients with type 2 diabetes on background glimepiride therapy, but not metformin, addition of ranolazine is associated with a significant reduction in hemoglobin A1c (HbA1c), according to research published ...

Diabetes

Basal insulin peglispro beats glargine for glycemic control

(HealthDay)—For patients with type 2 diabetes, basal insulin peglispro (BIL) provides better glycemic control than insulin glargine, with increased triglycerides, aminotransferases, and liver fat content, according to a ...

Cardiology

Modest predictive power for HbA1c in atherosclerotic CVD risk

(HealthDay)—In the context of conventional cardiovascular disease (CVD) risk factors, hemoglobin A1c (HbA1c) has a modest effect on predicted atherosclerotic CVD risk, according to a study published online Sept. 8 in Circulation: ...

Diabetes

Modest relation between HbA1c, cardiovascular events

(HealthDay)—For patients with type 2 diabetes, hemoglobin A1c (HbA1c) is not significantly associated with cardiovascular events, regardless of clinical manifestation of vascular disease, according to a study published ...

Diabetes

Time-updated hemoglobin A1c variables linked to MI risk

(HealthDay)—Time-updated hemoglobin A1c (HbA1c) variables have a stronger association with myocardial infarction (MI) than baseline HbA1c, according to a study published online May 26 in Diabetes Care.

Diabetes

Changes observed in HbA1c during ramadan

(HealthDay)—For patients with type 2 diabetes, during Ramadan, the greatest change among metabolic parameters is seen for glycemia, according to a study published online May 13 in the Journal of Diabetes Investigation.

Diabetes

Early insulin initiation beneficial in seniors with T2DM

(HealthDay)—For older Medicare beneficiaries with type 2 diabetes mellitus (T2DM), early insulin initiation offers clinical benefit, according to a study published online May 8 in the Journal of the American Geriatrics ...

page 8 from 12